Table 2.
Biomarker molecules among the driver genes.
| Biomarker gene | Biomarker application |
|---|---|
| ADAM12 | Diagnosis |
| AGR3 | Diagnosis |
| AURKA | Efficacy |
| BCL2 | Diagnosis, efficacy, prognosis |
| CLDN7 | Unspecified application |
| CRP | Diagnosis, disease progression, efficacy, prognosis, safety |
| CYP19A1 | Diagnosis, efficacy |
| DCC | Prognosis |
| EXO1 | Diagnosis |
| FGFR2 | Diagnosis, response to therapy |
| GSTM1 | Diagnosis, efficacy, safety |
| HLTF | Diagnosis |
| ICAM1 | Diagnosis, efficacy, prognosis |
| IDO1 | Disease progression, efficacy, prognosis |
| IGF2BP3 | Diagnosis |
| IL6 | Diagnosis, disease progression, efficacy, prognosis, response to therapy, safety |
| IL6R | Efficacy |
| INHBA | Diagnosis |
| INSR | Prognosis |
| MGMT | Diagnosis, efficacy, prognosis |
| MS4A1 | Efficacy, prognosis |
| MUC4 | Diagnosis, disease progression |
| OVGP1 | Diagnosis |
| PTGS1 | Efficacy |
| PTK2 | Diagnosis, disease progression, efficacy, prognosis |
| PTP4A3 | Disease progression |
| SLC16A1 | Diagnosis |
| SMAD4 | Prognosis |
| STK11 | Diagnosis |
| TP53 | Diagnosis, disease progression, efficacy, prognosis, response to therapy |
| ZNF217 | Prognosis |